Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Allscripts Hlthcare (MDRX)

Allscripts Hlthcare (MDRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,072,200
  • Shares Outstanding, K 162,701
  • Annual Sales, $ 1,772 M
  • Annual Income, $ -182,180 K
  • 60-Month Beta 1.42
  • Price/Sales 0.62
  • Price/Cash Flow 3.28
  • Price/Book 0.85

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.10
  • Number of Estimates 8
  • High Estimate 0.14
  • Low Estimate 0.08
  • Prior Year 0.10
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.56 +44.52%
on 03/17/20
7.97 -17.31%
on 03/02/20
-1.32 (-16.69%)
since 02/27/20
3-Month
4.56 +44.52%
on 03/17/20
9.99 -34.03%
on 12/30/19
-3.30 (-33.37%)
since 12/27/19
52-Week
4.56 +44.52%
on 03/17/20
12.02 -45.17%
on 07/01/19
-3.11 (-32.06%)
since 03/27/19

Most Recent Stories

More News
CarePort enables safe transitions of care during COVID-19 outbreak

CarePort Health, a wholly-owned subsidiary of Allscripts (NASDAQ: MDRX) that connects 1,000 hospitals with 180,000 post-acute providers, is launching the COVID-19 Transitions of Care ("TOC") Hub as an...

MDRX : 6.59 (-2.23%)
The Global Care Management Solution Market is expected to grow from USD 9,236.12 Million in 2018 to USD 28,120.23 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 17.23%

Reportlinker.com announces the release of the report "Global Care Management Solution Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to...

MDRX : 6.59 (-2.23%)
CERN : 60.01 (-1.69%)
CRM : 146.00 (-5.64%)
Teladoc Inc has the Best Relative Performance in the Health Care Technology Industry (TDOC , HMSY , MDRX , VEEV , CERN )

We looked at the Health Care Technology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. ...

MDRX : 6.59 (-2.23%)
HMSY : 24.87 (-0.52%)
TDOC : 164.16 (+2.92%)
Allscripts response to the COVID-19 outbreak

Allscripts (NASDAQ: MDRX) is taking several steps to further its commitment to help fight the global spread of COVID-19. The company is working closely with health agencies and governments around the world...

MDRX : 6.59 (-2.23%)
Downtrend Call Working As Allscripts Healt Stock Falls 43.8% (MDRX)

SmarTrend identified a Downtrend for Allscripts Healt (NASDAQ:MDRX) on December 5th, 2019 at $10.05. In approximately 3 months, Allscripts Healt has returned 43.83% as of today's recent price of $5.65....

MDRX : 6.59 (-2.23%)
Allscripts Receives Infoway 2017 Edition Certification

Canada Health Infoway (Infoway) and Allscripts Healthcare Solutions (NASDAQ: MDRX) announced today that Allscripts SunriseTM has achieved Infoway certification under the 2017 Edition Release 2 of pre-implementation...

MDRX : 6.59 (-2.23%)
Allscripts announces full support of HHS' commitment to patients with final interoperability rules

Allscripts Healthcare Solutions (NASDAQ: MDRX) announced today its support for the two transformative regulations recently released by the U.S. Department of Health and Human Services' (HHS), believing...

MDRX : 6.59 (-2.23%)
Veradigm RxTruePrice Helps Drive Higher Medication Adherence

Allscripts Healthcare Solutions (NASDAQ: MDRX) and its payer and life science business unit, Veradigm(TM), announced its findings on the impact of Veradigm's RxTruePrice(TM), a solution designed to address...

MDRX : 6.59 (-2.23%)
Allscripts' Veradigm Business Line Unveils New Solution

Allscripts' (MDRX) Veradigm business line introduces new solution that will drive growing medication adherence and improve patient care.

SYK : 159.22 (-2.52%)
MDRX : 6.59 (-2.23%)
HAE : 100.95 (-3.71%)
NUVA : 46.93 (-6.38%)
Best Relative Performance in the Health Care Technology Industry Detected in Shares of Allscripts Healt (MDRX , TDOC , CERN , VCRA , VEEV )

We looked at the Health Care Technology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. ...

MDRX : 6.59 (-2.23%)
CERN : 60.01 (-1.69%)
TDOC : 164.16 (+2.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade MDRX with:

Business Summary

Allscripts Healthcare Solutions, Inc. offers clinical software, services, information and connectivity solutions that enable physicians and healthcare providers to deliver patients safety and clinical outcomes in the US. The Company provides intuitive clinical and business solutions including Electronic...

See More

Key Turning Points

2nd Resistance Point 7.34
1st Resistance Point 6.96
Last Price 6.59
1st Support Level 6.23
2nd Support Level 5.87

See More

52-Week High 12.02
Fibonacci 61.8% 9.17
Fibonacci 50% 8.29
Fibonacci 38.2% 7.41
Last Price 6.59
52-Week Low 4.56

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar